Riverhead Capital Management’s Mesa Laboratories MLAB Stock Holding History

Riverhead Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$119K	Buy	+500	New	+$116K	﹤0.01%	1290

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Riverhead Capital Management's MLAB Position: Q3 2019 in Review

Riverhead Capital Management opened a new position in Mesa Laboratories (MLAB) in Q3 2019: 500 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #1290 among its holdings.

144 funds tracked by Wall St. Rank hold MLAB as of Q3 2019.

Riverhead Capital Management held 500 shares of Mesa Laboratories worth $119K as of Q3 2019.
Mesa Laboratories was a new Riverhead Capital Management position in Q3 2019.
Mesa Laboratories made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1290 holding.
144 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.